甲状腺疾病与心血管疾病研究进展  

Progress of Thyroid Diseases and Cardiovascular Disease Research

作　　者：侯振江[1] 侯建章[2] 王凤玲[1] 

机构地区：[1]沧州医学高等专科学校医学技术系,河北沧州061001 [2]沧州医学高等专科学校医学系,河北沧州061001

出　　处：《医学综述》2015年第23期4296-4298,共3页Medical Recapitulate

基　　金：沧州医学高等专科学校科技支撑计划项目(2014Z001);河北省科技计划项目(15277796D)

摘　　要：甲状腺疾病是内分泌系统的常见病和多发病,与血糖、血脂及代谢综合征的相关性引起了人们的广泛关注。胱抑素C可在一定程度上反映冠状动脉病变的严重程度,与冠状动脉粥样硬化性心脏病(冠心病)的危险因素(如三酰甘油、高密度脂蛋白胆固醇等)密切相关。甲状腺功能减退患者心血管疾病(CVD)患病率增高,尤其亚临床甲状腺功能异常与CVD危险因素的增加密切相关,还与血清同型半胱氨酸增高有关。因此,甲状腺疾病与CVD的相关性研究引起人们高度的重视。Thyroid disease is a common endocrine system disease. Blood lipid and metabolic syndrome related research has aroused wide concern, cystactin C levels reflect the severity of coronary artery lesions in a certain extent,and coronary heart disease risk factors such as triacylglycerol, high-density lipoprotein cholesterol and other closely related, hypothyroid patients the prevalence of cardiovascular disease （ CVD ） increased, especially the subclinical thyroid function is closely related to increased abnormality and risk factors for CVD, and significantly higher serum homocysteine. So the study on the correlation of thyroid diseases and CVD has attracted people＇s great attention.

关 键 词：甲状腺疾病 心血管疾病 胱抑素C 同型半胱氨酸 

分 类 号：R581[医药卫生—内分泌] R54[医药卫生—内科学]